Loading...
Ikonisys S.A.
ALIKO.PA•EURONEXT
Healthcare
Medical - Devices
€1.52
€0.00(0.00%)

Over the last four quarters, Ikonisys S.A.'s revenue moved from $128909.00 in Q2 2023 to $297541.00 in Q2 2024. Operating income in Q2 2024 was -$1.36M, with a strong operating margin of -457%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Ikonisys S.A. remained robust at -$1.33M, reflecting operational efficiency. Net income dropped to -$1.40M, with an EPS of -$0.13. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan